Latest News

Feb 19, 2026

Treg pioneer Bluestone joins Vie Ventures as it builds autoimmune portfolio

Feb 19, 2026

Vie Ventures Names Jeff Bluestone, PhD, as Managing Director

Jan 21, 2026

Interview with Vie Ventures Co-Founders Dr. Steven St. Peter and Dr. Luke Evnin and Senior Advisor Dr. Louis DeGennaro

Jan 5, 2026

Catalytic Capital in Biotech & VC Philanthropy: Redefining purpose-aligned capital in biotech

Dec 5, 2025

Two veterans from MPM have launched a new VC firm, Vie Ventures, that will focus on investing in the I&I space – and it will leverage collaborations with disease specific philanthropies

Dec 2, 2025

A Venture Fund that Leverages Patient Experts to Target Autoimmune Diseases (RARECast)